ArticleCureus2025
Pemphigus Revealing Profound Hypothyroidism: A Rare Association.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pemphigus vulgaris is a rare autoimmune bullous dermatosis, and while Hashimoto's thyroiditis is the leading cause of hypothyroidism, their association falls within the spectrum of polyautoimmunity. A 50-year-old female patient with no specific past medical history presented with a four-month history of a clinical picture combining erosive mucocutaneous bullous lesions and significant asthenia. Further history-taking revealed that the patient exhibited significant psychomotor retardation, accompanied by subtle systemic signs (psychomotor slowness, bradycardia, and lower limb edema). A thyroid workup was performed accordingly, revealing severe hypothyroidism (ultra-sensitive thyroid-stimulating hormone > 68 IU/L, with severely depressed free T4 secondary to Hashimoto's thyroiditis, which was confirmed by the positivity of anti-thyroid peroxidase antibodies and thyroid ultrasonography. The management initially combined general corticosteroid therapy with prednisone and hormone replacement therapy with levothyroxine, resulting in a favorable clinical outcome after two months of treatment for the pemphigus and the normalization of thyroid hormone levels. This association, although rare, is reported in the literature. It is explained by the existence of a common genetic background, notably involving certain HLA system haplotypes, as well as a global immune dysregulation favoring the emergence of multiple autoimmune pathologies in the same individual. This clinical observation highlights the importance of systematic screening for other autoimmune diseases, particularly thyroid disorders, in all patients with pemphigus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.